Viking Therapeutics Inc (VKTX)

10:04 AM

When the Price of (VKTX) Talks, People Listen - news.stocktradersdaily.com

10:04 AM

06:15 AM

The Smartest Biotech Stocks to Buy With $50 - The Motley Fool

06:15 AM

01:21 AM

Viking therapeutics director Rouan buys $29,942 in stock By Investing.com - Investing.com Canada

01:21 AM

Apr 02, 2025

Viking therapeutics director Rouan buys $29,942 in stock - Investing.com India

Apr 02, 2025

Apr 02, 2025

Director Rouan Sarah Kathryn bought $29,943 worth of shares (1,240 units at $24.15) (SEC Form 4) - Quantisnow

Apr 02, 2025

Apr 02, 2025

Viking Therapeutics, Down 40%, Just Reached a New Milestone. Is the Stock a Buy Now? - Yahoo Finance

Apr 02, 2025

Apr 01, 2025

Viking Therapeutics, Inc. (VKTX) Stock Slides as Market Rises: Facts to Know Before You Trade - MSN

Apr 01, 2025

Mar 31, 2025

Viking Therapeutics stock hits 52-week low at $24.03 By Investing.com - Investing.com Australia

Mar 31, 2025

Mar 31, 2025

Viking Therapeutics stock hits 52-week low at $24.03 - Investing.com India

Mar 31, 2025

Mar 31, 2025

Viking Therapeutics (NasdaqCM:VKTX) Seals Manufacturing Deal as Stock Declines 11% Over The Past Month - Yahoo Finance

Mar 31, 2025

Mar 31, 2025

Which Healthcare Stock Is the Best Buy Right Now? - MarketBeat

Mar 31, 2025

Mar 28, 2025

A Closer Look at Viking Therapeutics's Options Market Dynamics - Benzinga

Mar 28, 2025

Mar 28, 2025

Viking Therapeutics (NASDAQ:VKTX) Trading Down 3.4%What's Next? - MarketBeat

Mar 28, 2025

Mar 27, 2025

Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet - Yahoo Finance

Mar 27, 2025

Mar 27, 2025

VKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss Drug - Yahoo Finance

Mar 27, 2025

Mar 26, 2025

Viking Therapeutics Skids Despite 'Rapid' Enrollment In Obesity Pill Study - Investor's Business Daily

Mar 26, 2025

Mar 26, 2025

Health Care Down as Viking Slides -- Health Care Roundup - Marketscreener.com

Mar 26, 2025

Mar 26, 2025

Viking Therapeutics Completes Enrollment for Phase 2 Trial of Oral Obesity Tablet - Patient Care Online

Mar 26, 2025

Mar 26, 2025

Viking Therapeutics Announces Completion of Enrollment in Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity - MarketScreener

Mar 26, 2025

Mar 26, 2025

Major Milestone: Viking's Oral Weight Loss Drug Advances with 280-Patient Phase 2 Trial - Stock Titan

Mar 26, 2025

Mar 25, 2025

Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly - MSN

Mar 25, 2025

Mar 24, 2025

Viking Therapeutics, Inc. (VKTX) Rises But Trails Market: What Investors Should Know - MSN

Mar 24, 2025

Mar 24, 2025

(VKTX) Investment Analysis - Stock Traders Daily

Mar 24, 2025

Mar 21, 2025

Market Whales and Their Recent Bets on VKTX Options - Benzinga

Mar 21, 2025

Mar 20, 2025

1 Biotech Stock Down 52% That Could Soar by 233%, According to Wall Street - Yahoo Finance

Mar 20, 2025

Mar 19, 2025

Down 65% From Its 52-Week High, Is Viking Therapeutics Stock a Bargain Buy? - Nasdaq

Mar 19, 2025

Mar 18, 2025

Is Viking Therapeutics the Next Blockbuster GLP-1 Stock? - MarketBeat

Mar 18, 2025

Mar 17, 2025

Viking Therapeutics (NasdaqCM:VKTX) Soars 10% With CordenPharma Manufacturing Agreement - Yahoo Finance

Mar 17, 2025

Mar 16, 2025

Viking Therapeutics Starts Mid-Stage Study on Oral Weight-Loss Drug - MSN

Mar 16, 2025

Mar 15, 2025

Viking Therapeutics Just Inked A $150 Million Manufacturing Deal. Here's Why Shares Crumbled. - MSN

Mar 15, 2025

Mar 14, 2025

Health Care Down as Traders Seek Out Defensive Sectors -- Health Care Roundup -March 14, 2025 at 05:24 pm EDT - Marketscreener.com

Mar 14, 2025

Mar 14, 2025

Why Viking Therapeutics Inc. (VKTX) Is Skyrocketing Today? - MSN

Mar 14, 2025

Mar 13, 2025

Viking Therapeutics, Inc. (VKTX) Ascends While Market Falls: Some Facts to Note - MSN

Mar 13, 2025

Mar 13, 2025

Viking Therapeutics: No Buyout Needed Now (NASDAQ:VKTX) - Seeking Alpha

Mar 13, 2025

Mar 13, 2025

(VKTX) Long Term Investment Analysis - Stock Traders Daily

Mar 13, 2025

Mar 13, 2025

How to Play VKTX Stock Amid Manufacturing Deal With CordenPharma - Zacks Investment Research

Mar 13, 2025

Mar 13, 2025

Viking Therapeutics (NASDAQ:VKTX) Earns “Buy” Rating from HC Wainwright - Defense World

Mar 13, 2025

Mar 12, 2025

10 Stocks Skyrocketing Today - Insider Monkey

Mar 12, 2025

Mar 12, 2025

Why VKTX Stock is Moving Today - GuruFocus.com

Mar 12, 2025

Mar 12, 2025

Viking Therapeutics Secures Manufacturing Agreement with CordenPharma, Boosting Growth Prospects and Investor Appeal - TipRanks

Mar 12, 2025

Mar 12, 2025

Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped - Yahoo

Mar 12, 2025

Mar 12, 2025

Viking Therapeutics’ new contract is a game changer. Here’s how much money it could bring in. - MarketWatch

Mar 12, 2025

Mar 12, 2025

Behind the Scenes of Viking Therapeutics's Latest Options Trends - Benzinga

Mar 12, 2025

Mar 12, 2025

B. Riley sees two key positives in Viking manufacturing agreement - Yahoo Finance

Mar 12, 2025

Mar 12, 2025

Viking Therapeutics call volume above normal and directionally bullish - TipRanks

Mar 12, 2025

Mar 12, 2025

Viking shares slip after manufacturing deal announced - The Pharma Letter

Mar 12, 2025

Mar 12, 2025

VKTX Inks Manufacturing Deal With CordenPharma for Obesity Drug Supply - Yahoo Finance

Mar 12, 2025